Primary |
Dementia Alzheimer's Type |
39.9% |
Drug Use For Unknown Indication |
12.8% |
Dementia |
12.2% |
Hypertension |
7.5% |
Product Used For Unknown Indication |
5.8% |
Depression |
3.7% |
Osteoporosis |
2.3% |
Parkinson's Disease |
1.8% |
Dementia With Lewy Bodies |
1.7% |
Amnesia |
1.7% |
Constipation |
1.4% |
Memory Impairment |
1.4% |
Insomnia |
1.3% |
Atrial Fibrillation |
1.3% |
Diabetes Mellitus |
1.2% |
Cognitive Disorder |
1.0% |
Vascular Dementia |
0.9% |
Cardiac Failure Congestive |
0.7% |
Dizziness |
0.7% |
Hypothyroidism |
0.7% |
|
Rhabdomyolysis |
12.1% |
Syncope |
11.1% |
Vomiting |
10.1% |
Electrocardiogram Qt Prolonged |
7.6% |
Sudden Death |
7.0% |
Convulsion |
5.1% |
Tremor |
5.1% |
Altered State Of Consciousness |
4.4% |
Bradycardia |
4.0% |
Torsade De Pointes |
4.0% |
Ventricular Tachycardia |
3.7% |
Pneumonia |
3.6% |
Drug Interaction |
3.4% |
Somnolence |
3.3% |
Delirium |
3.1% |
Overdose |
2.8% |
Death |
2.3% |
Fall |
2.3% |
Nausea |
2.3% |
Sinus Bradycardia |
2.3% |
|
Secondary |
Dementia Alzheimer's Type |
28.1% |
Dementia |
11.7% |
Drug Use For Unknown Indication |
11.1% |
Product Used For Unknown Indication |
10.7% |
Hypertension |
9.9% |
Depression |
4.6% |
Parkinson's Disease |
2.7% |
Dementia With Lewy Bodies |
2.3% |
Insomnia |
2.3% |
Diabetes Mellitus |
2.0% |
Anxiety |
1.7% |
Pain |
1.7% |
Ill-defined Disorder |
1.6% |
Blood Pressure Abnormal |
1.6% |
Osteoporosis |
1.5% |
Prostatic Disorder |
1.5% |
Essential Hypertension |
1.4% |
Atrial Fibrillation |
1.2% |
Amnesia |
1.2% |
Gastritis |
1.2% |
|
Syncope |
15.2% |
Vomiting |
7.7% |
Somnolence |
6.1% |
Electrocardiogram Qt Prolonged |
5.9% |
Rhabdomyolysis |
5.9% |
Urinary Tract Infection |
5.9% |
Tremor |
5.7% |
Loss Of Consciousness |
5.1% |
Weight Decreased |
4.9% |
Altered State Of Consciousness |
4.3% |
Overdose |
3.9% |
Bradycardia |
3.7% |
Malaise |
3.7% |
Arrhythmia |
3.4% |
Convulsion |
3.4% |
Fall |
3.4% |
Dementia |
3.0% |
Hallucination |
3.0% |
Nausea |
3.0% |
Delirium |
2.8% |
|
Concomitant |
Product Used For Unknown Indication |
24.4% |
Drug Use For Unknown Indication |
13.2% |
Dementia Alzheimer's Type |
10.2% |
Hypertension |
8.8% |
Dementia |
7.3% |
Depression |
4.6% |
Multiple Sclerosis |
3.6% |
Pain |
3.5% |
Osteoporosis |
3.2% |
Atrial Fibrillation |
3.0% |
Parkinson's Disease |
3.0% |
Diabetes Mellitus |
2.3% |
Insomnia |
2.2% |
Constipation |
2.0% |
Prophylaxis |
1.8% |
Memory Impairment |
1.8% |
Multiple Myeloma |
1.4% |
Blood Cholesterol Increased |
1.3% |
Gastrooesophageal Reflux Disease |
1.2% |
Anxiety |
1.1% |
|
Vomiting |
10.2% |
Urinary Tract Infection |
9.3% |
Weight Decreased |
8.4% |
Somnolence |
7.3% |
Death |
6.4% |
Tremor |
6.3% |
Weight Increased |
6.3% |
Pneumonia |
4.7% |
Syncope |
4.2% |
Nausea |
4.0% |
Drug Ineffective |
3.9% |
Pyrexia |
3.5% |
Fall |
3.5% |
Myocardial Infarction |
3.4% |
White Blood Cell Count Increased |
3.4% |
Dementia |
3.3% |
White Blood Cell Count Decreased |
3.2% |
Renal Failure |
3.1% |
Rash |
3.0% |
Loss Of Consciousness |
2.7% |
|
Interacting |
Hypertension |
22.6% |
Dementia |
11.9% |
Product Used For Unknown Indication |
9.7% |
Prostatic Disorder |
7.9% |
Blood Pressure Abnormal |
5.8% |
Dementia Alzheimer's Type |
5.2% |
Cardiac Disorder |
4.0% |
Insomnia |
3.2% |
Amnesia |
2.9% |
Bronchopulmonary Aspergillosis |
2.9% |
Nervousness |
2.9% |
Urine Flow Decreased |
2.9% |
Nervous System Disorder |
2.7% |
Drug Use For Unknown Indication |
2.5% |
Mineral Supplementation |
2.5% |
Osteoporosis |
2.5% |
Depression |
2.3% |
Anxiety |
2.0% |
Diabetes Mellitus |
1.8% |
Hypothyroidism |
1.6% |
|
Drug Interaction |
29.3% |
Balance Disorder |
8.7% |
Vitamin D Decreased |
8.7% |
Nausea |
6.5% |
Hallucination |
5.4% |
Hiccups |
5.4% |
Vertigo |
4.3% |
Liver Disorder |
3.3% |
Loss Of Consciousness |
3.3% |
Upper Respiratory Tract Inflammation |
3.3% |
Abnormal Behaviour |
2.2% |
Blood Urine Present |
2.2% |
Electrocardiogram Qt Prolonged |
2.2% |
Gastric Ulcer |
2.2% |
Hypertensive Crisis |
2.2% |
Hypotension |
2.2% |
Mental Status Changes |
2.2% |
Renal Failure |
2.2% |
Salivary Hypersecretion |
2.2% |
Sinus Bradycardia |
2.2% |
|